Clinical Trials in Skincare: How They Work
Phrases like clinically proven, clinical trial, and dermatologist-tested appear on a substantial proportion of skincare products. The meaning behind those phrases varies enormously. This page outlines how skincare clinical trials are actually designed, what distinguishes a robust trial from a weak one, and what readers can sensibly take from clinical claims when they encounter them.
What counts as a clinical trial
In a medical-research context, a clinical trial is a prospective study in human participants designed to test a specific hypothesis about an intervention.
Trials vary widely in design - randomised or not, controlled or not, blinded or not, of varying duration and sample size. The phrase clinical trial alone does not specify any of these characteristics.
In skincare, the term is used more loosely. A product described as clinically tested may have been studied in anywhere from a dozen to several hundred participants, over varying periods, with measurement methods varying from self-reported satisfaction to instrumented measurement of barrier function or imaging-based assessment of inflammatory lesion counts.
What distinguishes a more rigorous trial
Several features tend to mark a more credible skincare trial. Adequate sample size for the effect being claimed. Defined inclusion and exclusion criteria for participants.
Randomised assignment to product or control. Blinded assessment, where the evaluator does not know which participants used which product.
Objective measurement methods that do not depend solely on participant report. Pre-specified outcomes rather than outcomes selected after data collection. Independent ethics review through an Institutional Review Board or equivalent.
A trial that includes most of these features is more likely to produce results that hold up under independent replication. A trial that includes few of them may still be informative but should be read more cautiously.
Common limitations in commercial skincare trials
Most clinical trials supporting skincare product claims are sponsored by the company selling the product. This is not inherently disqualifying - most clinical research in many fields is industry-sponsored but it introduces incentive structures that affect study design, outcome selection, and reporting.
Common limitations include small sample sizes, short trial durations often insufficient to assess durability of effect, heavy reliance on self-reported outcomes, lack of blinded assessment, and selective publication of favourable results.
Comparison against a true placebo or no-treatment control is less common than comparison against a competitor product, which is a less rigorous standard.
What to look for as a reader
The most informative thing a reader can usually do with a clinical claim is read it carefully. Phrases like clinically proven to reduce blemishes are vague: by how much, in how many participants, over what period, measured how?
Specific claims with specific numbers are more useful than general claims, even if the underlying study has limitations.
Independent dermatologist commentary, peer-reviewed publication of trial results, and registration of the trial in a public registry such as ClinicalTrials.gov are additional signals of rigour, although their absence does not necessarily mean a trial is unsound.
Where the field is heading
Skincare clinical research has become more rigorous over the past decade, partly driven by regulatory pressure and partly by the entry of biotech-trained scientists into the formulation space.
Larger, longer, better-controlled trials are more common than they were ten years ago, although the headline marketing claim is rarely a good guide to whether a specific product sits at the rigorous or loose end of the spectrum.
When to Seek Additional Guidance
This page is part of a small editorial archive on skincare science. It is not medical advice. Anyone considering changes to a skincare regimen should consult a registered medical practitioner.